1. Academic Validation
  2. Scalable syntheses of the BET bromodomain inhibitor JQ1

Scalable syntheses of the BET bromodomain inhibitor JQ1

  • Tetrahedron Lett. 2015 Jun 3;56(23):3354-3457. doi: 10.1016/j.tetlet.2015.02.062.
Shameem Sultana Syeda 1 Sudhakar Jakkaraj 1 Gunda I Georg 1
Affiliations

Affiliation

  • 1 Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, United States of America.
Abstract

We have developed methods involving the use of alternate, safer reagents for the scalable syntheses of the potent BET bromodomain inhibitor JQ1. A one-pot three step method, involving the conversion of a benzodiazepine to a thioamde using Lawesson's reagent, followed by amidrazone formation and installation of the triazole moiety furnished JQ1. This method provides good yields and a facile purification process. For the synthesis of enantiomerically enriched (+)-JQ1, the highly toxic reagent diethyl chlorophosphate, used in a previous synthesis, was replaced with the safer reagent diphenyl chlorophosphate in the three-step one-pot triazole formation without effecting yields and enantiomeric purity of (+)-JQ1.

Keywords

BET inhibitors; Bromodomains; Male contraceptive; One-pot method; Thionation; Triazolothienodiazepine (+)-JQ1.

Figures
Products